Evidence map›Paper›PMID 34956868›Full record

ArticleFrontiers in oncology2021

Clinical Significance and Prognostic Value of the Maximum Standardized Uptake Value of

Yi-Xin Yin, Ming-Zhi Xie, Xin-Qiang Liang, Meng-Ling Ye, Ji-Lin Li, Bang-Li Hu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Texture analysis of [European journal of nuclear medicine and molecular imaging · 2026
    Observational
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Relationship of FDG PET/CT imaging features with tumor immune microenvironment and prognosis in colorectal cancer: a retrospective study.Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Article
  8. Preoperative metabolic parameters ofQuantitative imaging in medicine and surgery · 2024
    Article
  9. Article
  10. The Role and Potential ofDiagnostics (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yi-Xin YinDepartment of Research, Guangxi Medical University Cancer Hospital, Nanning, China.
Ming-Zhi XieDepartment of Chemotherapy, Guangxi Medical University Cancer Hospital, Nanning, China.
Xin-Qiang LiangDepartment of Research, Guangxi Medical University Cancer Hospital, Nanning, China.
Meng-Ling YeDepartment of Research, Guangxi Medical University Cancer Hospital, Nanning, China.
Ji-Lin LiDepartment of Research, Guangxi Medical University Cancer Hospital, Nanning, China.
Bang-Li HuDepartment of Research, Guangxi Medical University Cancer Hospital, Nanning, China.
Guangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe role of

methodsData of 66 patients with CRC who underwent

resultsBy analyzing the data of 66 patients with CRC, the SUVmax was found not to be related to the tumor-node-metastasis stage, clinical stage, sex, and KRAS mutation but was related to the tumor location and nerve invasion. The SUVmax had no significant correlation with the tumor biomarkers and the Ki-67 index. Data of 17 studies indicated that the SUVmax was significantly increased in the mutated type compared with the wild type of KRAS in CRC; four studies showed that there was no remarkable difference between patients with a high and low Ki-67 index score regarding the SUVmax. Twelve studies revealed that the SUVmax had no significant association with overall survival and disease-free survival in CRC patients.

conclusionsBased on the combined data, this study demonstrated that the SUVmax of

Indexed as

18FDG-PET/CTcolorectal cancerKi-67KRASprognosisSUVmax

Identifiers

PMID34956868
PMCPMC8695495
OpenAlexW4200275064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.